The hard road to data interpretation: 3 or 6 months of adjuvant chemotherapy for patients with stage III colon cancer?

BACKGROUND: Six months of adjuvant oxaliplatin-based chemotherapy is standard for patients with stage III colon cancer following surgery. However, oxaliplatin is associated with peripheral neurotoxicity which worsens over treatment duration. Consequently, a shorter treatment duration, if equally eff...

Täydet tiedot

Tallennettuna:
Bibliografiset tiedot
Julkaisussa:Ann Oncol
Päätekijät: Sobrero, A, Grothey, A, Iveson, T, Labianca, R, Yoshino, T, Taieb, J, Maughan, T, Buyse, M, André, T, Meyerhardt, J, Shields, A F, Souglakos, I, Douillard, J -Y, Cervantes, A
Aineistotyyppi: Artigo
Kieli:Inglês
Julkaistu: Oxford University Press 2018
Aiheet:
Special Article
Linkit:https://ncbi.nlm.nih.gov/pmc/articles/PMC6864492/
https://ncbi.nlm.nih.gov/pubmed/29438451
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/annonc/mdy064
Tagit: Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!

Samankaltaisia teoksia